We report on the application of a venovenous type extracorporeal membrane oxygenator (ECMO) in high-risk tracheal procedures in six cases consisting of five patients with tracheal stenosis. An ECMO should be helpful for preventing respiratory emergency during a tracheal procedure. 
month prior. The trachea mass was located 3 cm below the vocal cord and was worsening the dyspnea (Fig. 1A, B) . For symptom relief, mass excision using rigid bronchoscopic cryotherapy was planned. During the procedure, extracorporeal lung assist was also planned to prevent complications such as respiratory arrest due to airway obstruction and a prolonged procedure. 
DISCUSSION
The first case of non-cardiac surgical application of ex- adenoma. Phillips et al. [2] described the percutaneous use of extracorporeal circulation in 1983. In 1996, Horita et al. [3] reported that a venovenous bypass with an oxygenator via a percutaneous femoral venous approach was used to perform carinal reconstruction. Choi and Kim [4] reported that tracheostomy was used to assist with an emergency bypass system in a case of severe tracheal stenosis in 2007.
The causes of tracheal stenosis are numerous. The most common cause is post-intubation and tracheostomy. In addition, inflammatory diseases, tumor, and trauma can all be factors. In general, surgical treatment has had good results [5, 6] . However, in our cases, the length of the stenosis was long or the lesion was below the vocal cords, and the causes of the tracheal stenosis were unresectable tumors; thus, palliative methods were chosen.
An ECMO has usually been applied in rescue situations.
However, in our cases, because airway obstruction was predicted during the procedure, we decided to make preparations using venovenous ECMO. During ECMO perfusion, the surgeons could concentrate on the procedure without worrying about the patients' oxygenation. Alexander has also reported a case of ECMO preparation during rigid bronchoscopic tracheal stent removal. After the first attempted stent removal in the operation room had failed because of an airway obstruction, venoarterial ECMO assist was performed, and the stent was removed successfully [7] .
Currently our institutional indication for extracorporeal lung assist in a tracheal procedure is that airway obstruction is expected during the procedure due to severe tracheal stenosis, and the tracheal procedure is difficult and time-consuming, due to issues such as ruptured tracheal stent removal.
However, the ECMO also has its own risks, such as thromboembolism and bleeding due to anticoagulation. To reduce the complications, we chose the venovenous type ECMO and nafamostat mesilate as an anticoagulant for some cases.
However, the duration of ECMO was quite long because we tended to wean the patients from the ECMO slowly. One death from bleeding occurred. By applying an ECMO only when necessary and according to the indications and reducing the ECMO duration, the procedure can be performed more
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In our cases, for anticoagulation during ECMO perfusion, initial heparin bolus was infused, followed by continuous infusion of heparin or nafamostat mesilate for maintenance.
Nafamostat mesilate, a synthetic protease inhibitor with a short half-life, has been widely used as an anticoagulant to reduce bleeding in hemodialysis patients. It has been reported that nafamostat mesilate also produces good results when it is applied for anticoagulation in cardiac surgery with an ECMO.
However, various dosages were used in each study [8] . To avoid bleeding complications in our stent removal and cryotherapy cases, nafamostat mesilate was used. There was no thromboembolism or oxygenator malfunction during ECMO perfusion, but one bleeding complication had occurred. More studies are needed for determining the appropriate nafamostat mesilate dosage in ECMO perfusion.
